UTMB’s Thomas Geisbert was quoted for a story on a new Ebola vaccine that is 100 percent effective. Geisbert, who was not part of the study, questioned the vaccine’s long-term effectiveness. "Is it still protective, for example, 2–3 years after the vaccination?" Geisbert asked according to Vox. This news also reported in True Viral News, LidTime.com, CNBC, Yahoo! News Canada, Health Medicine Network, CBC News, Medscape and MedCity News.